ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
14.02
-0.47 (-3.24%)
At close: Dec 26, 2025, 4:00 PM EST
14.05
+0.03 (0.21%)
After-hours: Dec 26, 2025, 5:42 PM EST
ClearPoint Neuro Revenue
ClearPoint Neuro had revenue of $8.86M in the quarter ending September 30, 2025, with 9.10% growth. This brings the company's revenue in the last twelve months to $34.33M, up 12.83% year-over-year. In the year 2024, ClearPoint Neuro had annual revenue of $31.39M with 31.04% growth.
Revenue (ttm)
$34.33M
Revenue Growth
+12.83%
P/S Ratio
11.43
Revenue / Employee
$298,539
Employees
115
Market Cap
417.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.39M | 7.44M | 31.04% |
| Dec 31, 2023 | 23.96M | 3.40M | 16.56% |
| Dec 31, 2022 | 20.55M | 4.25M | 26.09% |
| Dec 31, 2021 | 16.30M | 3.47M | 27.05% |
| Dec 31, 2020 | 12.83M | 1.61M | 14.37% |
| Dec 31, 2019 | 11.22M | 3.86M | 52.54% |
| Dec 31, 2018 | 7.35M | -26.26K | -0.36% |
| Dec 31, 2017 | 7.38M | 1.63M | 28.35% |
| Dec 31, 2016 | 5.75M | 1.16M | 25.15% |
| Dec 31, 2015 | 4.59M | 989.71K | 27.46% |
| Dec 31, 2014 | 3.60M | -326.09K | -8.30% |
| Dec 31, 2013 | 3.93M | -1.13M | -22.29% |
| Dec 31, 2012 | 5.06M | 1.24M | 32.48% |
| Dec 31, 2011 | 3.82M | 1.15M | 43.03% |
| Dec 31, 2010 | 2.67M | 69.45K | 2.67% |
| Dec 31, 2009 | 2.60M | 650.00K | 33.33% |
| Dec 31, 2008 | 1.95M | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CLPT News
- 5 weeks ago - ClearPoint Neuro Completes Acquisition of IRRAS - Accesswire
- 6 weeks ago - ClearPoint Neuro, Inc. (CLPT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - ClearPoint Neuro: CRO Facility Should Reaccelerate Growth - Seeking Alpha
- 7 weeks ago - ClearPoint Neuro Reports Third Quarter 2025 Results - Accesswire
- 7 weeks ago - ClearPoint Neuro Announces Agreement to Acquire IRRAS - Accesswire
- 7 weeks ago - ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025 - Accesswire
- 2 months ago - ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles - Accesswire
- 2 months ago - ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide - Accesswire